What blood tests diagnose lupus (SLE)?

The ANA (antinuclear antibody) test is the primary screening tool; it is positive in >95% of lupus cases. If positive, anti-dsDNA and anti-Sm antibodies are checked as they are highly specific for SLE. Complement levels (C3 and C4) are typically low during active lupus. A full blood count often shows anaemia, leukopenia, or thrombocytopenia.

What are the most common symptoms of lupus?

Common symptoms include a butterfly-shaped rash across the cheeks and nose (malar rash), fatigue, joint pain and swelling, photosensitivity, mouth sores, and hair loss. Lupus can also affect the kidneys (lupus nephritis), heart, lungs, and central nervous system.

How is lupus monitored over time?

Regular monitoring includes anti-dsDNA antibody titres (rise with flares), complement levels (C3/C4 fall during active disease), urinalysis and urine protein-to-creatinine ratio for kidney involvement, full blood count for cytopenias, and CRP/ESR to assess inflammation. Anti-dsDNA and complement tests together are the most reliable activity markers.

Is lupus different in men and women?

Lupus predominantly affects women of childbearing age at a ratio of about 9:1 (female to male). However, men with lupus often experience more severe disease, higher rates of kidney and serositis involvement, and a higher risk of thrombosis. Hormonal factors, particularly oestrogen, are thought to play a role in the female predominance.

Lupus (SLE): Symptoms, ANA & Anti-dsDNA Blood Tests

Common Symptoms

Joint pain and swelling (arthritis)
Butterfly-shaped facial rash across cheeks and nose
Extreme fatigue
Photosensitivity: rash worsens with sun exposure
Mouth ulcers
Hair loss
Fever without infection
Chest pain when breathing deeply (pleurisy)

Diagnostic Blood Tests

Test	Purpose	Notes
ANA (antinuclear antibody)	Screening test: positive in >95% of lupus	Not specific: positive in many other conditions and some healthy people
Anti-dsDNA	Highly specific for lupus	Levels correlate with disease activity, especially kidney involvement
Anti-Smith (anti-Sm)	Very specific for lupus	Less sensitive but highly specific
Complement (C3, C4)	Low levels indicate active disease	Falls during flares
FBC	Anaemia, low white cells, low platelets common
Urinalysis + protein:creatinine ratio	Screens for lupus nephritis (kidney involvement)

Treatment Approach

Severity	Treatment
Mild (joint/skin)	Hydroxychloroquine (cornerstone treatment for almost all lupus patients); NSAIDs
Moderate	Add low-dose steroids, possibly methotrexate or azathioprine
Severe (organ-threatening, e.g. kidney)	High-dose steroids + immunosuppressants (mycophenolate, cyclophosphamide); biologics (belimumab, rituximab)

Lupus Nephritis WarningKidney involvement (lupus nephritis) affects up to 50% of lupus patients and can be silent until significant damage occurs. Regular urine testing (protein:creatinine ratio) is essential even without symptoms, as early treatment prevents kidney failure.

Hydroxychloroquine Is for LifeHydroxychloroquine is recommended for nearly all lupus patients long-term, even during remission, as it reduces flare frequency, protects organs, and improves survival. Annual eye checks are needed due to a small risk of retinal toxicity with long-term use.

Is lupus the same as rheumatoid arthritis?

No. While both are autoimmune conditions causing joint pain, lupus can affect many organs (skin, kidneys, brain, blood) beyond joints, and has different antibody patterns and treatments.

Can lupus be cured?

No cure currently exists, but modern treatment allows most people with lupus to live full lives with good disease control, especially with early diagnosis and consistent treatment.

Does sun exposure really trigger lupus flares?

Yes. UV light is a well-documented trigger for lupus flares, particularly skin and systemic symptoms. Sun protection (SPF 50+, protective clothing) is an essential part of lupus management.

References

The clinical information on this page is drawn from peer-reviewed sources indexed by the US National Library of Medicine. Links go to the source so you can read it yourself.

Systemic Lupus Erythematosus. In: StatPearls. Treasure Island (FL): StatPearls Publishing. NCBI Bookshelf NBK535405

References

Sources cited on this page. PubMed links open the original abstract.

Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–2121. PMID 22136079 · doi:10.1056/NEJMra1100359

The SLICC criteria – how SLE is diagnosed today

Systemic lupus erythematosus (SLE) is diagnosed using the 2012 SLICC (Systemic Lupus International Collaborating Clinics) criteria or the 2019 EULAR/ACR criteria – both of which require a combination of clinical features and immunological markers. SLE cannot be diagnosed on blood tests alone; the clinical picture is essential.

The SLICC criteria require either: lupus nephritis confirmed by biopsy (standalone criterion), or 4 or more of 11 clinical + 6 immunological criteria (with at least one clinical and one immunological). Key criteria:

Clinical: Malar rash (butterfly rash), discoid rash, non-scarring alopecia, oral ulcers, photosensitivity, serositis (pleuritis or pericarditis), synovitis (joint involvement without erosion), renal disorder, haematological disorder (haemolytic anaemia, leukopenia, lymphopenia, thrombocytopenia), neurological disorder (seizures, psychosis, mononeuritis multiplex)
Immunological: Positive ANA, anti-dsDNA, anti-Sm, anti-phospholipid antibodies, low complement (C3, C4), positive direct Coombs test

Key blood tests and what they reflect in SLE

Anti-dsDNA: Rises before lupus flares, particularly renal flares. Serial monitoring guides treatment escalation. High anti-dsDNA + low C3/C4 = active lupus nephritis until proven otherwise.
Complement C3 and C4: Consumed during immune complex deposition. Both fall in active disease. C4 is genetically influenced – some patients have constitutionally low C4 (null alleles), complicating interpretation.
Urinalysis and urine protein-to-creatinine ratio (PCR): Lupus nephritis presents as proteinuria (protein in urine), haematuria (red cells – "red cell casts" are pathognomonic), and eventually rising creatinine. Urine PCR above 50 mg/mmol warrants urgent nephrology referral and consideration of renal biopsy to classify the histological pattern (WHO class I–VI lupus nephritis), which determines treatment intensity.
Anti-phospholipid antibodies (lupus anticoagulant, anti-cardiolipin IgG/IgM, anti-β2GP1): Present in approximately 30–40% of SLE patients. Antiphospholipid syndrome (APS) – the triad of thrombosis, recurrent miscarriage, and positive antibodies – can coexist with SLE or occur independently. Lifelong anticoagulation is required once APS is confirmed with a thrombotic event.

Lupus (SLE): Diagnosis & Treatment Guide

Common Symptoms

Diagnostic Blood Tests

Treatment Approach

References

References

The SLICC criteria – how SLE is diagnosed today

Key blood tests and what they reflect in SLE

Related reading